Serum Endostatin Type 2 Diabetic Patients

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

March 2, 2017

Primary Completion Date

November 11, 2017

Study Completion Date

December 20, 2017

Conditions
Diabetes Mellitus, Type 2Coronary Artery DiseaseCoronary Arteriosclerosis
Interventions
DIAGNOSTIC_TEST

serum endostatin level

"An oral (metoprolol 20 mg) was given to the patients with heart rates \> 60 beats/minute and had no contraindications to beta-blockers, one hour before the scan. Sublingual nitroglycerin was given to all patients before CT examination. A 64-slice CT scanner (Sensation 64; Siemens Medical System, Germany) was used for imaging all subjects. All CT examinations were done during inspiratory breath holding.~Endostatin levels were measured using a sandwich ELISA kit according to the manufacturer's instructions endostatin ELISA kit (R\&D Systems, Minneapolis, Minnesota, USA"

Trial Locations (1)

44519

Zagazig University, Faculty of Medicine, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT03404037 - Serum Endostatin Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter